3-羟基丙酸乙酯 | 623-72-3

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 羧酸酯及其衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 中文名称: 3-羟基丙酸乙酯
• 英文名称: ethyl 3-hydroxypropanoate
• 英文别名: ethyl 3-hydroxypropionate；3-hydroxy-propionic acid ethyl ester；2-hydroxyethane-carboxylic acid-ethylester
• CAS: 623-72-3
• 化学式: C₅H₁₀O₃
• mdl: MFCD11652203
• 分子量: 118.133
• InChiKey: UKDLORMZNPQILV-UHFFFAOYSA-N

物化性质

• 沸点：
  187.5°C (estimate)
• 密度：
  1.054
• LogP：
  -0.43 at 23.8℃
• 表面张力：
  70.67mN/m at 1g/L and 20℃

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2918199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥环境中保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl 3-hydroxypropanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 3-hydroxypropanoate
CAS number: 623-72-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H10O3
Molecular weight: 118.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-羟基丙酸乙酯 在 氨 、 zirconium(IV) oxide 作用下， 生成 丙烯腈
  参考文献：
  名称：

  [EN] SYSTEMS AND METHODS FOR PRODUCING NITRILES
  [FR] SYSTÈMES ET PROCÉDÉS DE PRODUCTION DE NITRILES

  摘要：

  本公开的一个方面是一种方法，其中首先将来自至少一种羧酸、羧酸酯和/或酸酐的分子与氨发生反应，形成腈，其中第一反应是在酸催化剂的作用下催化的。在本公开的一些实施例中，该分子可能包括乙酸、乳酸和/或3-羟基丙酸（3-HPA）中的至少一种。在本公开的一些实施例中，该分子可能包括醋酸甲酯、乙酸乙酯和/或3-羟基丙酸乙酯（乙基3-HP）中的至少一种。在本公开的一些实施例中，酸酐可能是醋酸酐。

  公开号：

  WO2017143124A1
• 作为产物：
  描述：

  2,3-环氧丙酸乙酯 在 potassium biphenyle 、 水 作用下， 生成 3-羟基丙酸乙酯
  参考文献：
  名称：

  Bartmann, Ekkehard, Angewandte Chemie, 1986, vol. 98, # 7, p. 629 - 631

  摘要：

  DOI：
• 作为试剂：
  描述：

  2,3-epoxy-1,2,3,4-tetrahydronaphthalene 以 乙醇 、 3-羟基丙酸乙酯 、 异丙胺 为溶剂， 生成 trans-1,2,3,4-tetrahydro-3-[(1-methylethyl)amino]-2-naphthalenol
  参考文献：
  名称：

  5,6,7,8-Tetrahydronaphthalene hypotensive agents

  摘要：

  具有结构式##STR1##和其药学上可接受的盐的5,6,7,8-四氢萘烯可用作降压剂。在上述公式中，R.sub.1可以是氢或烷基；R.sub.2是烷基；R.sub.3和R.sub.4可以分别是氢、羟基、烷氧基或芳基烷氧基，但两者不能都是羟基。其中至少一个R.sub.3和R.sub.4不是氢的化合物是新颖的，并构成本发明的一部分。

  公开号：

  US04076843A1

文献信息

• Nucleosides. Part LXIII. Acetals as new 2?-O-protecting functions for the synthesis of oligoribonucleotides: Synthesis of uridine building blocks and evaluation of their relative acid stability
  作者：Stefan Matysiak、Hans-Peter Fitznar、Ralf Schnell、Wolfgang Pfleiderer

  DOI：10.1002/hlca.19980810557

  日期：——

  A broad variety of new acyclic vinyl ethers (see 6–41) have been synthesized via the vinyl-interchange reaction of ethyl vinyl ether at room temperature using mercury(II) trifluoroacetate as a highly efficient catalyst. The appropriate vinyl ethers were reacted under acidic conditions with 3′,5′-O-silyl-protected uridine 42 to the corresponding 2′-O-(1-alkoxyethyl) derivatives 43–83 which gave, on

  各种各样的新的无环乙烯基醚（见6 - 41）已被合成通过在室温下的乙基乙烯基醚的乙烯基-交换反应使用汞（II）三氟乙酸盐作为一种高效催化剂。适当的乙烯基醚是在酸性条件下反应，用3'，5'- ø -甲硅烷保护的尿苷42到相应的2'- ø - （1-烷氧基乙基）衍生物43 - 83这给了，对于F的脱甲硅烷基-离子，高产率的尿苷2'- O-缩醛衍生物84 – 124。使用TLC和HPLC技术确定了新合成化合物在酸性和碱性条件下的相对稳定性。受保护的保护基为寡核糖核苷酸合成提供了最佳性能。有趣的是，β-取代的乙基型的非常酸稳定缩醛118 - 121和123可以由β消去过程中提供了一系列潜在的合成值的碱不稳定的乙缩醛的裂解。
• Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor
  作者：He Tian、Wei Liu、Zhixing Zhou、Qian Shang、Yuqiang Liu、Yafei Xie、Changying Liu、Weiren Xu、Lida Tang、Jianwu Wang、Guilong Zhao

  DOI：10.3390/molecules21111543

  日期：——

  In order to systematically explore and understand the structure–activity relationship (SAR) of a lesinurad-based hit (1c) derived from the replacement of the S atom in lesinurad with CH2, 18 compounds (1a–1r) were designed, synthesized and subjected to in vitro URAT1 inhibitory assay. The SAR exploration led to the discovery of a highly potent flexible URAT1 inhibitor, 1q, which was 31-fold more potent than parent lesinurad (IC50 = 0.23 μM against human URAT1 for 1q vs 7.18 μM for lesinurad). The present study discovered a flexible molecular scaffold, as represented by 1q, which might serve as a promising prototype scaffold for further development of potent URAT1 inhibitors, and also demonstrated that the S atom in lesinurad was not indispensable for its URAT1 inhibitory activity.

  为了系统地探索和理解基于lesinurad的命中化合物（1c）的结构-活性关系（SAR），该化合物是通过将lesinurad中的S原子替换为CH2得到的，设计并合成了18个化合物（1a–1r），并对其进行了体外URAT1抑制活性测试。SAR探索发现了一个高效的柔性URAT1抑制剂1q，其活性比母体lesinurad高31倍（对于人URAT1的IC50值，1q为0.23 μM，而lesinurad为7.18 μM）。本研究发现了一种柔性分子骨架，如1q所示，这可能作为进一步开发高效URAT1抑制剂的有前景的原型骨架，并且表明lesinurad中的S原子对其URAT1抑制活性并非必需。
• [EN] FUSED [1,2,4]THIADIAZINE DERIVATIVES WHICH ACT AS KAT INHIBITORS OF THE MYST FAMILY<br/>[FR] DÉRIVÉS DE [1,2,4]THIADIAZINE FUSIONNÉS AGISSANT EN TANT QU'INHIBITEURS DE KAT DE LA FAMILLE DES MYST
  申请人：CTXT PTY LTD

  公开号：WO2019043139A1

  公开（公告）日：2019-03-07

  A compound of formula (I): which inhibits the activity of one or more KATs of the MYST family, i.e., TIP60, KAT6B, MOZ, HBO1 and MOF.

  一种化合物的化学式（I）：抑制MYST家族中一个或多个KATs的活性，即TIP60、KAT6B、MOZ、HBO1和MOF。
• INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS AND USE OF SAME IN MEDICINE
  申请人：ADLAI NORTYE BIOPHARMA CO., LTD.

  公开号：US20200331887A1

  公开（公告）日：2020-10-22

  The present invention relates to a compound represented by formula I, a pharmaceutical composition containing the compound of formula I, a method for inhibiting indoleamine 2,3-dioxygenase, and its use in medicine.

  本发明涉及一种由公式I表示的化合物、含有公式I化合物的药物组合物、用于抑制吲哚胺2,3-双加氧酶的方法及其在医学上的应用。
• Renin inhibitors
  申请人：American Cyanamid Company

  公开号：US05104869A1

  公开（公告）日：1992-04-14

  Renin inhibiting compounds containing a single .alpha.-amino acid of the formula: ##STR1## and analogs thereof which inhibit the substrate-cleaving acting or renin, pharmaceutical compositions containing these compounds, processes for producing the compounds and methods of treating hypertension which employ the novel renin inhibitors.

  含有单个α-氨基酸的抑制肾素化合物的翻译：##STR1##及其类似物，这些化合物抑制肾素的底物裂解作用，含有这些化合物的药物组合物，生产这些化合物的方法以及使用新型肾素抑制剂治疗高血压的方法。